Ipratropium bromide inhalation solution
Function and Efficacy
Not yet clear.
Ingredients
Chemical name: (8γ)-3α-hydroxy-8-isopropyl-1αH, 5αH-tropine bromide (±)-tropine salt monohydrate (= ipratropium bromide monohydrate) Molecular weight: C20H30BrNO3·H2O
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Ipratropium bromideIngredients |
Not yet clear More |
22254-24-6 | 40 |
Appearance
Colorless or almost colorless clear liquid.
Indication
Used to treat reversible airway obstruction caused by acute or chronic asthma.
Usage and Dosage
The dosage should be adjusted according to the individual needs of the patient; the patient should be under medical supervision during treatment.
Adverse Reactions
Not yet clear.
Precautions
People who are allergic to this product are prohibited from using it, and those with allergic constitutions should use it with caution.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
1. β-receptor agonists and xanthine preparations can enhance bronchodilator effects. 2. When ipratropium bromide and β-agonists are used together, patients with a history of narrow-angle glaucoma may increase the risk of acute glaucoma attacks.
Storage
seal.
Packaging Specification
20ml:5mg
Validity Period
24 months
Manufacturer
Jewim Pharmaceutical (Shandong) Co., Ltd.
-
Founded in:
1993-12-17 -
Address:
West end of Peitianmen Street, High-tech Industrial Development Zone, Tai'an City, Shandong Province -
Tax NO.:
91370900613681048D -
Registered Funds:
118.8505098 yuan -
Website:
-
Email: